Literature DB >> 25959112

In response to "In utero exposure to methotrexate and risk of congenital malformations".

April L Dawson1, Tiffany Riehle-Colarusso1, Jennita Reefhuis1, J Fernando Arena1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25959112      PMCID： PMC4618601          DOI： 10.1002/ajmg.a.37151

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN： 1552-4825            Impact factor:   2.802


× No keyword cloud information.
  3 in total

1.  Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy.

Authors:  Sarah H Poggi; Alessandro Ghidini
Journal:  Fertil Steril       Date:  2011-07-05       Impact factor: 7.329

2.  Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?

Authors:  Kurt D Piggott; Andrea Sorbello; Elise Riddle; William DeCampli
Journal:  Pediatr Cardiol       Date:  2011-02-17       Impact factor: 1.655

3.  Maternal exposure to methotrexate and birth defects: a population-based study.

Authors:  April L Dawson; Tiffany Riehle-Colarusso; Jennita Reefhuis; J Fernando Arena
Journal:  Am J Med Genet A       Date:  2014-06-04       Impact factor: 2.802
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.